Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2013 by Aarhus University Hospital.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Louise Tram Henriksen, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT01272440
First received: January 5, 2011
Last updated: November 12, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)